Nykredit Realkredit A/S
17.3.2021 13:55:54 CET | Globenewswire | Press release
To Nasdaq Copenhagen
17 March 2021
CORRECTION Nykredit Realkredit A/S – New final terms for Euro Medium Term Note Programme
Nykredit Realkredit A/S publishes final terms for an issue of EUR 50,000,000 0.01% Senior Non-Preferred Notes due 2024, which are issued pursuant to Nykredit Realkredit A/S's and Nykredit Bank A/S’s €10,000,000,000 Euro Medium Term Note Programme dated 13 May 2020.
The final terms dated 17 March 2021 and the EMTN Programme dated 13 May 2020 are available for download on Nykredit's website at nykredit.com/ir.
A previous version of this announcement incorrectly contained the words "Floating Rate" rate in the title of the Final Terms.
Enquiries may be addressed to Nykredit Realkredit A/S, Nicolaj Verdelin, Head of Funding Trading, Funding & Capital, tel +45 44 55 11 25, or Morten Bækmand Niel-sen, Head of Investor Relations, tel +45 44 55 15 21.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.17.9.2026 22:15:00 CEST | Press release
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
Chint Global17.9.2026 21:05:04 CEST | Press release
CHINT Presents Advanced Grid Solutions for Europe in Paris
Scandinavian Investment Group A/S17.9.2026 20:52:10 CEST | Pressemeddelelse
Ledende medarbejders handel med aktier
F. Hoffmann-La Roche Ltd17.9.2026 20:30:00 CEST | Press release
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Serstech17.9.2026 18:40:00 CEST | Press release
Serstech receives 10.7 MSEK order from US partner WS Darley and co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
